Article Information
History
- February 19, 2021.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
Author Information
- Madhusudhanan Narasimhan, PhD, MSHA1,
- Lenin Mahimainathan, PhD, MB(ASCP)1,
- Ellen Araj, MD1,
- Andrew E. Clark, PhD, DABMM1,
- John Markantonis, DO1,
- Allen Green, MD1,
- Jing Xu, MD, PhD1,
- Jeffrey A. SoRelle, MD1,
- Charles Alexis, MT(ASCP)1,
- Kimberly Fankhauser, MT(ASCP)1,
- Hiren Parikh, MT(ASCP)1,
- Kathleen Wilkinson, MS2,
- Annika Reczek, MS2,
- Noa Kopplin, BS2,
- Sruthi Yekkaluri, MS2,
- Jyoti Balani, MD1,
- Abey Thomas, MD2,
- Amit Singal, MD2,
- Ravi Sarode, MD1,2 and
- Alagarraju Muthukumar, PhD, DABCC1,*
- 1Department of Pathology, University of Texas Southwestern Medical Center, Dallas, Texas
- 2Department of Internal Medicine, University of Texas Southwestern Medical Center, Dallas, Texas
- ↵*Corresponding author:
Alagarraju Muthukumar, PhD, DABCC, Assistant Professor of Pathology, UT Southwestern Medical Center, Dallas, Email: alagarraju.muthukumar{at}utsouthwestern.edu, Ph: 214-645-5103, Fax: 214-645-5106
Posted February 19, 2021.
Clinical evaluation of the Abbott Alinity SARS-CoV-2 spike-specific quantitative IgG and IgM assays in infected, recovered, and vaccinated groups
